Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 71335-9605

7 FDA label images from Bryant Ranch Prepack · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 71335-9605). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Venlafaxinestructure (Venlafaxinestructure)

Venlafaxinestructure (Venlafaxinestructure)
Chemical structure of Venlafaxine Hydrochloride, showing the arrangement of atoms including a methoxy-substituted aromatic ring, a chiral center, and an extended amine group with hydrochloride component.*
FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
A scatter plot figure depicting pharmacokinetic changes in venlafaxine under various special population conditions. The x-axis shows 'Change relative to the reference value' from 0 to 3.5, with a vertical reference line at 1. The y-axis lists special populations including hepatic cirrhosis, mild and moderate hepatic impairment, renal impairment, hemodialysis, CYP2D6 metabolizer status, age over 60 years, and gender. The analyte measured is venlafaxine with pharmacokinetic parameters Cmax, AUC, and ODV at different time points, with dots representing fold changes and 90% confidence intervals.*
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
A chart showing the fold change and 90% confidence intervals of pharmacokinetic parameters (Cmax, AUC, ODV) for venlafaxine when interacting with various drugs including ethanol, diazepam, cimetidine, ketoconazole (in CYP2D6 EMs and PMs), indinavir, metoprolol, imipramine, and lithium. The x-axis represents change relative to the reference value with a scale from 0 to 3.*
FDA Label Image

Figure-3 (Figure 3)

Figure-3 (Figure 3)
A forest plot chart displaying the fold change and 90% confidence interval in pharmacokinetic parameters (Cmax, AUC) of various analytes when interacting with the drug, including ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, tolbutamide, and lithium. The x-axis shows the change relative to the reference value from 0 to 3.*
FDA Label Image

Logo1 (Logo1)

FDA Label Image

Logo2 (Logo2)

FDA Label Image

Label (Lbl713359605)

Label (Lbl713359605)
Label for Venlafaxine ER 37.5 mg extended release capsule by Bryant Ranch Prepack, packaged in Burbank, CA. The label compares the product to Effexor XR 37.5 mg capsule. It indicates a package quantity of 30 capsules and displays storage instructions (store at room temperature 20°-25°C). The label also warns the medication may cause drowsiness and includes a barcode and NDC 71335-9605.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.